TY - JOUR
T1 - Amyloid β-peptide [1-42]-assosiated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain
T2 - Mechanisms and consequences
AU - Butterfield, D. Allan
PY - 2003
Y1 - 2003
N2 - In addition to synapse loss, neurofibrillary tangles, and neurodegeneration, oxidative stress and amyloid β-peptide [Aβ] deposition are hallmarks of Alzheimer's disease [AD] brain. Our laboratory coupled these two characteristics of AD into a comprehensive model to account for the synapse loss and neurodegeneration in AD brain. This model combines much of the extant studies on AD and is based on oxidative stress associated with amyloid β-peptide. This review presents evidence in support of this model and provides insight into the molecular basis of this devastating dementing disorder.
AB - In addition to synapse loss, neurofibrillary tangles, and neurodegeneration, oxidative stress and amyloid β-peptide [Aβ] deposition are hallmarks of Alzheimer's disease [AD] brain. Our laboratory coupled these two characteristics of AD into a comprehensive model to account for the synapse loss and neurodegeneration in AD brain. This model combines much of the extant studies on AD and is based on oxidative stress associated with amyloid β-peptide. This review presents evidence in support of this model and provides insight into the molecular basis of this devastating dementing disorder.
KW - Amyloid β-peptide
KW - Free radicals proteomics
KW - Lipid peroxidation
KW - Neurodegeneration
KW - Oxidative stress
KW - Protein oxidation
UR - http://www.scopus.com/inward/record.url?scp=0344824654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344824654&partnerID=8YFLogxK
U2 - 10.2174/0929867033456422
DO - 10.2174/0929867033456422
M3 - Review article
C2 - 14529455
AN - SCOPUS:0344824654
SN - 0929-8673
VL - 10
SP - 2651
EP - 2659
JO - Current Medicinal Chemistry
JF - Current Medicinal Chemistry
IS - 24
ER -